• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Taxus Cardium Pharmaceuticals Group Inc

+ Add to Watchlist


1.050 EUR 0.0000.00%

As of 02:39:03 ET on 12/29/2014.

Snapshot for Taxus Cardium Pharmaceuticals Group Inc (42CN)

Open: 1.050 Day's Range: 1.050 - 1.050 Volume: 0
Previous Close: 1.050 52wk Range: 0.269 - 1.050 1-Yr Rtn: +83.57%

Stock Chart for 42CN

No chart data available.
  • 42CN:GR 1.050
  • 1D
  • 1M
  • 1Y
Interactive 42CN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 42CN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 12.92
Shares Outstanding (M) 12.31
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 42CN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 42CN

Taxus Cardium Pharmaceuticals Group Inc is a late-stage clinical and commercial therapeutics company. The Company develops regenerative medicine therapeutics, used in interventional cardiology, angiogenic gene therapy and for the treatment of cardiac microvascular insufficiency.

Christopher J ReinhardChairman/Pres/CEO/TreasurerDennis M MulroyChief Financial Officer
Gabor M RubanyiChief Scientific OfficerTyler M Dylan-HydeExec VP/Chief Bus Ofcr/Secy
More Company Profile & Key Executives for 42CN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil